ObsEva SA [NASDAQ: OBSV] loss -5.12% on the last trading session, reaching $2.04 price per share at the time. The company report on December 1, 2020 that ObsEva SA to present at The International Society of Gynecological Endocrinology 19th World Congress – virtual edition, December 2-5, 2020.
Geneva, Switzerland and Boston, MA – December 1, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health announced that Ernest Loumaye, MD, PhD, co-founder and member of the Board of Directors, will give a presentation at the ISGE (International Society of Gynecological Endocrinology) 19th World Congress Virtual Edition, December 2-5, 2020.
ObsEva SA represents 50.09 million in outstanding shares, while the company has a total market value of $108.47 million with the latest information. OBSV stock price has been found in the range of $2.02 to $2.155.
If compared to the average trading volume of 624.29K shares, OBSV reached a trading volume of 1094238 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ObsEva SA [OBSV]:
JP Morgan have made an estimate for ObsEva SA shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on November 09, 2020. While these analysts kept the previous recommendation, JP Morgan raised their target price from $18 to $5. The new note on the price target was released on July 07, 2020, representing the official price target for ObsEva SA stock. Previously, the target price had yet another drop from $5 to $4, while BMO Capital Markets kept a Market Perform rating on OBSV stock. On November 08, 2019, analysts decreased their price target for OBSV shares from 16 to 4.
The Average True Range (ATR) for ObsEva SA is set at 0.13, with the Price to Sales ratio for OBSV stock in the period of the last 12 months amounting to 6779.17. The Price to Book ratio for the last quarter was 4.64, with the Price to Cash per share for the same quarter was set at 0.95.
Trading performance analysis for OBSV stock
ObsEva SA [OBSV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.62. With this latest performance, OBSV shares gained by 6.25% in over the last four-week period, additionally sinking by -57.41% over the last 6 months – not to mention a drop of -54.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OBSV stock in for the last two-week period is set at 44.83, with the RSI for the last a single of trading hit 47.03, and the three-weeks RSI is set at 44.00 for ObsEva SA [OBSV]. The present Moving Average for the last 50 days of trading for this stock 2.21, while it was recorded at 2.11 for the last single week of trading, and 2.96 for the last 200 days.
ObsEva SA [OBSV]: A deeper dive into fundamental analysis
Return on Total Capital for OBSV is now -96.09, given the latest momentum, and Return on Invested Capital for the company is -97.86. Return on Equity for this stock declined to -111.08, with Return on Assets sitting at -80.17. When it comes to the capital structure of this company, ObsEva SA [OBSV] has a Total Debt to Total Equity ratio set at 55.31. Additionally, OBSV Total Debt to Total Capital is recorded at 35.61, with Total Debt to Total Assets ending up at 26.05. Long-Term Debt to Equity for the company is recorded at 54.05, with the Long-Term Debt to Total Capital now at 34.80.
Reflecting on the efficiency of the workforce at the company, ObsEva SA [OBSV] managed to generate an average of -$2,171,457 per employee.ObsEva SA’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.10.
ObsEva SA [OBSV]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, ObsEva SA posted -0.48/share EPS, while the average EPS was predicted by analysts to be reported at -0.58/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 17.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OBSV.
An analysis of insider ownership at ObsEva SA [OBSV]
There are presently around $57 million, or 48.10% of OBSV stock, in the hands of institutional investors. The top three institutional holders of OBSV stocks are: SOFINNOVA INVESTMENTS, INC. with ownership of 4,749,623, which is approximately 0% of the company’s market cap and around 5.54% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 4,586,563 shares of the stock with an approximate value of $9.36 million in OBSV stocks shares; and ARMISTICE CAPITAL, LLC, currently with $8.85 million in OBSV stock with ownership of nearly New of the company’s market capitalization.
Positions in ObsEva SA stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 28 institutional holders increased their position in ObsEva SA [NASDAQ:OBSV] by around 5,542,199 shares. Additionally, 24 investors decreased positions by around 4,589,608 shares, while 13 investors held positions by with 17,777,605 shares. The mentioned changes placed institutional holdings at 27,909,412 shares, according to the latest SEC report filing. OBSV stock had 15 new institutional investments in for a total of 4,832,020 shares, while 16 institutional investors sold positions of 1,957,576 shares during the same period.